MSI2 and hepatocellular carcinoma: It is reported that MSI2 can take part in post-transcriptional regulation through associating with specific mRNAs and that it may participate in the modulation of proliferation and maintenance of stem cells in the central nervous system [46, 47], and it has recently demonstrated a potential as a predictive biomarker of HCC prognosis [48].